These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20609201)

  • 21. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.
    Taube T; Schmid H; Reinhard H; von Stackelberg A; Overberg US
    Haematologica; 2005 Feb; 90(2):281-3. PubMed ID: 15710595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
    Cooper N; Evangelista ML; Amadori S; Stasi R
    Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rituximab monoclonal antibody in the treatment of retractable idiopathic thrombocytopenic purpura--a case report].
    Zhou N; Hua BL; Wang SJ; Zhu TN; Zhao YQ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):432. PubMed ID: 15854541
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab.
    Stosic M; De Jesus P; McCarthy J; Hutton G; Rivera V
    Neurology; 2011 Aug; 77(5):505-7. PubMed ID: 21775738
    [No Abstract]   [Full Text] [Related]  

  • 25. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia.
    Zaja F; Vianelli N; Battista M; Sperotto A; Patriarca F; Tomadini V; Filì C; Tani M; Baccarani M; Fanin R
    Exp Hematol; 2006 May; 34(5):571-2. PubMed ID: 16647558
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
    Patino W; Sarode R
    J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of rituximab in refractory autoimmune thrombocytopenia following an autologous stem cell transplant.
    Price S; Cumpston A; Altaha R
    Hematology; 2006 Feb; 11(1):43-4. PubMed ID: 16522548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura.
    Bengtson KL; Skinner MA; Ware RE
    J Pediatr; 2003 Nov; 143(5):670-3. PubMed ID: 14615744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with rituximab of autoimmune disease: results from AADEA's registry].
    Callejas Rubio JL; Camps MT; García-Hernández F;
    Med Clin (Barc); 2008 Jan; 130(2):79. PubMed ID: 18221681
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.
    Lee JW; Kim HA; Sung JM; Suh CH
    Lupus; 2010 Feb; 19(2):227-8. PubMed ID: 19884220
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiphospholipids antibodies in a 12-month-old presenting with idiopathic thrombocytopenic purpura.
    Nseir B; Panicker J
    Pediatr Hematol Oncol; 2008; 25(3):233-5. PubMed ID: 18432507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic thrombocytopenic purpura: a revolution of biological therapy?].
    Bierling P; Godeau B
    Rev Prat; 2009 May; 59(5):606-7. PubMed ID: 19552194
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange.
    Basquiera AL; Damonte JC; Abichaín P; Sturich AG; García JJ
    Ann Hematol; 2008 Apr; 87(4):321-3. PubMed ID: 17899079
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rituximab treatment of chronic idiopathic thrombocytopenic purpura. Results of a phase II study].
    Meo P; Stipa E; La Presa M; Bianchi M; Di Giulio C; Stasi R; Amadori S
    Recenti Prog Med; 2002; 93(7-8):421-7. PubMed ID: 12138687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
    Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
    Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
    Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME
    Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab for patients with idiopathic thrombocytopenic purpura.
    Peñalver FJ; Cabrera JR
    Ann Intern Med; 2007 Aug; 147(4):281; author reply 281-2. PubMed ID: 17709765
    [No Abstract]   [Full Text] [Related]  

  • 39. [Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].
    Fríguls-Francitorra B; Almazán-Castro F; Manchón GJ
    Med Clin (Barc); 2006 Sep; 127(12):478-9. PubMed ID: 17040639
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient.
    Ross CL; Hunt BJ; Wyncoll D; Hodgkiss A; Peters B
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):157-60. PubMed ID: 19339839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.